Can your genes predict blood thinner success? new study targets caribbean hispanics
NCT ID NCT03419325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 150 Caribbean Hispanic adults with heart disease or stroke risk who take the blood thinner clopidogrel. Researchers wanted to see if certain gene variants affect how well the drug works. The goal is to understand why some people get less benefit and to pave the way for more personalized treatment in this diverse population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiovascular Hospital of Puerto Rico and the Caribbean
San Juan, 00926, Puerto Rico
-
University Hospital at Carolina
Carolina, 00984, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Can immune cells predict how well the heart heals after an attack?
- Spinal zaps could reboot breathing after brain injury
- Heart patients may stay active longer with coach calls and group support
- Can brain scans reveal hidden language struggles after stroke?
- Could a hot bath after exercise help heal the heart?